Relay Therapeutics Inc (NASDAQ: RLAY) open the trading on Wednesday, with great promise as it jumped 1.75% to $7.54, before settling in for the price of $7.41 at the close. Taking a more long-term approach, RLAY posted a 52-week range of $1.77-$9.04.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -23.05%. Meanwhile, its Annual Earning per share during the time was -23.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 26.63%. This publicly-traded company’s shares outstanding now amounts to $172.63 million, simultaneously with a float of $130.45 million. The organization now has a market capitalization sitting at $1.31 billion.
Relay Therapeutics Inc (RLAY) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Relay Therapeutics Inc’s current insider ownership accounts for 24.73%, in contrast to 74.77% institutional ownership. According to the most recent insider trade that took place on Jan 06 ’26, this organization’s President and CEO sold 43,168 shares at the rate of 7.82, making the entire transaction reach 337,574 in total value, affecting insider ownership by 661,041. Preceding that transaction, on Nov 03 ’25, Company’s President and CEO sold 62,073 for 7.00, making the whole transaction’s value amount to 434,511. This particular insider is now the holder of 703,215 in total.
Relay Therapeutics Inc (RLAY) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
Relay Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 26.63% and is forecasted to reach -1.66 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.64% through the next 5 years, which can be compared against the -23.05% growth it accomplished over the previous five years trading on the market.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Let’s observe the current performance indicators for Relay Therapeutics Inc (RLAY). It’s Quick Ratio in the last reported quarter now stands at 19.14. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 156.32.
In the same vein, RLAY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.75, a figure that is expected to reach -0.40 in the next quarter, and analysts are predicting that it will be -1.66 at the market close of one year from today.
